Načítá se...
Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases
PURPOSE: To compare treatment plans and evaluate dosimetric characteristics of permanent cesium-131 ((131)Cs) vs. iodine-125 ((125)I) implants used in brain brachytherapy. MATERIAL AND METHODS: Twenty-four patients with (131)Cs implants from a prospective phase I/II trial were re-planned with (125)I...
Uloženo v:
| Vydáno v: | J Contemp Brachytherapy |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Termedia Publishing House
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7690233/ https://ncbi.nlm.nih.gov/pubmed/33293969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2020.98109 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|